Back to Stakeholders
Care Delivery & Psychedelic FacilitationClinical Care Delivery OrganizationsHealth Systems & Hospitals
Research, Drug Development & ManufacturingAcademic & Non-Profit Research
Research, Drug Development & ManufacturingAcademic & Non-Profit ResearchSpecialized Academic Departments and Institutes
Care Delivery & Psychedelic FacilitationClinical Care Delivery Organizations
Care Delivery & Psychedelic Facilitation
Research, Drug Development & Manufacturing

Shalvata Mental Health Center

Israel
3 Trials

Shalvata Mental Health Center is a 114-bed comprehensive psychiatric hospital founded in 1956 in Hod HaSharon, Israel, affiliated with Clalit Health Services and the Sackler Faculty of Medicine at Tel Aviv University; it is one of Israel's most active psychedelic research sites, having conducted trials comparing intranasal versus intravenous ketamine administration, MDMA-assisted psychotherapy for borderline personality disorder, and ketamine combined with cognitive behavioral analysis system of psychotherapy (CBASP) for chronic treatment-resistant depression.

Academic Research

0 papers

Published Papers

0

Trial Involvement

3

Distinct Focus Topics

0

Latest Publication

Unknown

Quick Facts

Type
Other
HQ
Israel
Website
Visit

Sponsored Trials

1
CompletedIV

Intra-nasal vs. Intra-venous Ketamine Administration

Start Date
Compounds
Ketamine, Placebo

Collaborated Trials

2
RecruitingII

MDMA in Borderline Personality Disorder (MDMA in BPD)

Start Date
Compounds
MDMA
RecruitingII

Pharmacologic Treatment Augmentation in Chronic Depression (Ket+CBASP)

Start Date
Compounds
Ketamine, Placebo